CD4 and pneumocystosis: We found that those who were HIV-positive and those with HIV and a CD4 cell count <200 cells/μl had significantly decreased IgM responses to Pneumocystis Msg fragments, and that other clinical predictors such as PCP prophylaxis and smoking were also associated with antibody responses to Msg.